Mark Skolnick and collaborators highlighted the importance of this abnormality when they identified a tumor suppressor locus harboring the gene for the cell cycle regulators INK4A and ARF (15), which are key regulators of the RB1 and p53 pathways, respectively. Here, CDKN2A is linked to neoplasm.